Serenza Therapeutics
PrivateLast Round
Series A
May 10, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Serenza Therapeutics is a biopharmaceutical company spun-out from Nxera Pharma to advance a preclinical GPCR-targeted program.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Serenza Therapeutics Comparables
Compare Serenza Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Confo Therapeutics | 77% | |
| Kainova Therapeutics | 76% | |
| Alkira Bio | 76% |
Serenza Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 10, 2026 |
Serenza Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Health Investors | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 10, 2026
Nxera Pharma Co., Ltd. led the round.
- Jan 19, 2025
Grew 19% QoQ, from 27 to 32 employees.
Serenza Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Serenza Therapeutics's valuation, stock price, and market status.
Is Serenza Therapeutics a public or private company?
Serenza Therapeutics is a private company.
What is the current stock price of Serenza Therapeutics?
Serenza Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Serenza Therapeutics worth (valuation)?
Valuation information for Serenza Therapeutics is not publicly available.
Can I buy Serenza Therapeutics stock?
Serenza Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Serenza Therapeutics's last funding round?
Serenza Therapeutics's most recent funding round was Series A on May 10, 2026.
Who are the main investors in Serenza Therapeutics?
Key investors in Serenza Therapeutics include SV Health Investors.
Will Serenza Therapeutics IPO soon?
No public IPO plans have been announced for Serenza Therapeutics.
How can I track Serenza Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Serenza Therapeutics's secondary market activity and sign up for updates.